These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 29907552)

  • 1. Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies.
    Thanarajasingam G; Minasian LM; Baron F; Cavalli F; De Claro RA; Dueck AC; El-Galaly TC; Everest N; Geissler J; Gisselbrecht C; Gribben J; Horowitz M; Ivy SP; Jacobson CA; Keating A; Kluetz PG; Krauss A; Kwong YL; Little RF; Mahon FX; Matasar MJ; Mateos MV; McCullough K; Miller RS; Mohty M; Moreau P; Morton LM; Nagai S; Rule S; Sloan J; Sonneveld P; Thompson CA; Tzogani K; van Leeuwen FE; Velikova G; Villa D; Wingard JR; Wintrich S; Seymour JF; Habermann TM
    Lancet Haematol; 2018 Nov; 5(11):e563-e598. PubMed ID: 29907552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies.
    Thanarajasingam G; Minasian LM; Bhatnagar V; Cavalli F; De Claro RA; Dueck AC; El-Galaly TC; Everest N; Geissler J; Gisselbrecht C; Gormley N; Gribben J; Horowitz M; Ivy SP; Jacobson CA; Keating A; Kluetz PG; Kwong YL; Little RF; Matasar MJ; Mateos MV; McCullough K; Miller RS; Mohty M; Moreau P; Morton LM; Nagai S; Nair A; Nastoupil L; Robertson K; Sidana S; Smedby KE; Sonneveld P; Tzogani K; van Leeuwen FE; Velikova G; Villa D; Wingard JR; Seymour JF; Habermann TM
    Lancet Haematol; 2022 May; 9(5):e374-e384. PubMed ID: 35483398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive approach to therapy of haematological malignancies in older patients.
    Cordoba R; Eyre TA; Klepin HD; Wildes TM; Goede V
    Lancet Haematol; 2021 Nov; 8(11):e840-e852. PubMed ID: 34624238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ESMO-Magnitude of Clinical Benefit Scale for haematological malignancies (ESMO-MCBS:H) version 1.0.
    Kiesewetter B; Dafni U; de Vries EGE; Barriuso J; Curigliano G; González-Calle V; Galotti M; Gyawali B; Huntly BJP; Jäger U; Latino NJ; Malcovati L; Oosting SF; Ossenkoppele G; Piccart M; Raderer M; Scarfò L; Trapani D; Zielinski CC; Wester R; Zygoura P; Macintyre E; Cherny NI;
    Ann Oncol; 2023 Sep; 34(9):734-771. PubMed ID: 37343663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aerobic physical exercise for adult patients with haematological malignancies.
    Bergenthal N; Will A; Streckmann F; Wolkewitz KD; Monsef I; Engert A; Elter T; Skoetz N
    Cochrane Database Syst Rev; 2014 Nov; (11):CD009075. PubMed ID: 25386666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aerobic physical exercise for adult patients with haematological malignancies.
    Knips L; Bergenthal N; Streckmann F; Monsef I; Elter T; Skoetz N
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD009075. PubMed ID: 30702150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reporting infections in clinical trials of patients with haematological malignancies.
    Tau N; Shargian-Alon L; Reich S; Paul M; Gafter-Gvili A; Shepshelovich D; Yahav D
    Clin Microbiol Infect; 2019 Dec; 25(12):1494-1500. PubMed ID: 31100423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yoga in addition to standard care for patients with haematological malignancies.
    Felbel S; Meerpohl JJ; Monsef I; Engert A; Skoetz N
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD010146. PubMed ID: 24919720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study.
    Passamonti F; Cattaneo C; Arcaini L; Bruna R; Cavo M; Merli F; Angelucci E; Krampera M; Cairoli R; Della Porta MG; Fracchiolla N; Ladetto M; Gambacorti Passerini C; Salvini M; Marchetti M; Lemoli R; Molteni A; Busca A; Cuneo A; Romano A; Giuliani N; Galimberti S; Corso A; Morotti A; Falini B; Billio A; Gherlinzoni F; Visani G; Tisi MC; Tafuri A; Tosi P; Lanza F; Massaia M; Turrini M; Ferrara F; Gurrieri C; Vallisa D; Martelli M; Derenzini E; Guarini A; Conconi A; Cuccaro A; Cudillo L; Russo D; Ciambelli F; Scattolin AM; Luppi M; Selleri C; Ortu La Barbera E; Ferrandina C; Di Renzo N; Olivieri A; Bocchia M; Gentile M; Marchesi F; Musto P; Federici AB; Candoni A; Venditti A; Fava C; Pinto A; Galieni P; Rigacci L; Armiento D; Pane F; Oberti M; Zappasodi P; Visco C; Franchi M; Grossi PA; Bertù L; Corrao G; Pagano L; Corradini P;
    Lancet Haematol; 2020 Oct; 7(10):e737-e745. PubMed ID: 32798473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study.
    Sant M; Minicozzi P; Mounier M; Anderson LA; Brenner H; Holleczek B; Marcos-Gragera R; Maynadié M; Monnereau A; Osca-Gelis G; Visser O; De Angelis R;
    Lancet Oncol; 2014 Aug; 15(9):931-42. PubMed ID: 25030467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of arsenic trioxide in haematological malignancies: insight into the clinical development of a novel agent.
    Amadori S; Fenaux P; Ludwig H; O'dwyer M; Sanz M
    Curr Med Res Opin; 2005 Mar; 21(3):403-11. PubMed ID: 15811209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition.
    Fisher SA; Cutler A; Doree C; Brunskill SJ; Stanworth SJ; Navarrete C; Girdlestone J
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD009768. PubMed ID: 30697701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of chimeric antigen receptor T-cell (CAR-T) therapy in patients with haematological and solid malignancies: protocol for a systematic review and meta-analysis.
    Grigor EJM; Fergusson DA; Haggar F; Kekre N; Atkins H; Shorr R; Holt RA; Hutton B; Ramsay T; Seftel M; Jonker D; Daugaard M; Thavorn K; Presseau J; Lalu MM
    BMJ Open; 2017 Dec; 7(12):e019321. PubMed ID: 29288188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palliative care specialists' perceptions concerning referral of haematology patients to their services: findings from a qualitative study.
    McCaughan D; Roman E; Smith AG; Garry AC; Johnson MJ; Patmore RD; Howard MR; Howell DA
    BMC Palliat Care; 2018 Feb; 17(1):33. PubMed ID: 29466968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The TREATT Trial (TRial to EvaluAte Tranexamic acid therapy in Thrombocytopenia): safety and efficacy of tranexamic acid in patients with haematological malignancies with severe thrombocytopenia: study protocol for a double-blind randomised controlled trial.
    Estcourt LJ; McQuilten Z; Powter G; Dyer C; Curnow E; Wood EM; Stanworth SJ;
    Trials; 2019 Oct; 20(1):592. PubMed ID: 31615553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Haematological malignancies: incidence in Basse-Normandie, France, for 1997-2004].
    Troussard X; Duchenet V; Cornet E; Mouchel D; Malet M; Collignon A
    Rev Epidemiol Sante Publique; 2009 Jun; 57(3):151-8. PubMed ID: 19375876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting infections in patients with haematological malignancies treated with chimeric antigen receptor T-cell therapies: A systematic scoping review and narrative synthesis.
    Reynolds G; Sim B; Anderson MA; Spelman T; Teh BW; Slavin MA; Thursky KA
    Clin Microbiol Infect; 2023 Oct; 29(10):1280-1288. PubMed ID: 37201866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.